











FBX-101 and the RESKUE Trial: Exploring AAV-Based Gene Therapies for Krabbe Disease










When Laboratory and Workplace Design Converge










Dr. Timothy J. Miller on building Ohio’s biotech hub and manufacturing gene therapies for life










Women of Influence: Erandi de Silva, Forge Biologics










No Disease is Safe with Dr. Tim Miller, Forge Biologics










CDMO With A Pipeline Featuring Forge Biologics President & CEO Dr. Timothy J. Miller










Forging Gene Therapy Capacity and a Pipeline at the Same Time









